Euphrates Vascular Announces FDA Clearance of the ICHOR Reperfusion System
Euphrates Vascular, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is designed to treat organized thrombus and embolic events in the peripheral vasculature. This "one size fits all" system is minimally invasive. - January 24, 2019
Pulse Therapeutics and ICHOR Vascular Merge to Form Euphrates Vascular
Company aimed at becoming a leader in the treatment of vascular occlusions. - January 13, 2019
Press Releases 1 - 2 of 2